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The main objective of this study is to establish potential neuromorphometric differences which might act
as markers of genetic risk for bipolar disorder and therefore serve as endophenotypes for discovery of
genes that contribute to bipolar disorder. Magnetic resonance imaging (MRI) was used to assess struc-
tural brain volumes of 49 subjects. Volumetric analyses were ﬁrst performed to test possible differences
in the volume of brain structures between subjects with bipolar disorder type I (BPI) and control subjects
in a new sample, based on regions previously reported in the literature as being either increased or
decreased in size in bipolar patients. Subsequently, for those brain regions showing statistical difference
between subjects with BPI and control subjects in our new sample, we tested whether unaffected ﬁrst
degree relatives (UFRs) of the BPI subjects also showed similar differences compared with controls. Four
speciﬁc regions (right prefrontal, right middle prefrontal, right globus pallidus and left globus pallidus)
met criteria for being possible endophenotypes for BPI in this sample.
& 2015 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY-NC-
ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Bipolar affective disorder type I (BPI) is a lifelong and poten-
tially devastating mood disorder characterized by one or more
episodes of mania often alternating with periods of depression
(American Psychiatric Association, 2013). Although research stu-
dies have suggested that there is a signiﬁcant genetic contribution
to the risk of BPI, large-scale genetic studies of BPI have thus far
had limited success in identifying the speciﬁc gene variants that
explain the heightened genetic risk for bipolar disorder. The clin-
ical complexity and the highly variable symptomatic presentation
of BPI make the identiﬁcation of these genes a challenging en-
deavor (Glahn et al., 2004).
Gottesman and Gould (2003) theorized that a promising ap-
proach for the study of the genetic components of mental dis-
orders would be to ﬁrst identify endophenotypes that arer Ireland Ltd. This is an open acces
Paso, TX 79902, USA.
amilla).genetically correlated with the particular mental disorder. An en-
dophenotype is a quantitative measure (Gottesman and Gould,
2003) that is altered in persons with the phenotype in comparison
to healthy controls. Ideally, an endophenotype for BPI should also
be altered in those who share genetic risk for a disease (i.e., ﬁrst
degree relatives of BPI patients; Glahn et al., 2007). One can then
identify the genes inﬂuencing these endophenotypes as a means
of better understanding the genetic factors responsible for the
phenotype of BPI.
Structural brain characteristics have been suggested as one
possible endophenotypic measure for BPI (Hariri and Weinberger,
2003; Glahn et al., 2007). Anatomical brain volumes are quanti-
tatively measurable, and recent research has suggested high her-
itability of volume in speciﬁc regions (Hariri and Weinberger,
2003; Glahn et al., 2007). In addition, a number of previous ima-
ging studies of bipolar disorder have suggested that there might be
an alteration of brain structures associated with BPI. In the present
article, we ﬁrst review the literature to identify brain regions that
have been shown to differ in size between subjects with BPI and
controls. We then test each of these regions in a new study sample,s article under the CC BY-NC-ND license
Table 1
Proposed structural endophenotypes for BPI based on literature review.
Regions of interest Volume change
in BPI cases vs.
controls
Volume change
in UFR cases vs.
controls
Source
Right prefrontal Reduced Lopez-L, 2002
Right middle
prefrontal
Reduced Lopez-L, 2002
Right inferior
prefrontal
Reduced Lopez-L. 2002,
Matsuo, 2012
Left prefrontal Reduced Lopez-L, 2002
Left superior
prefrontal
Reduced Lopez-L, 2002
Left middle
prefrontal
Reduced Lopez-L, 2002
Left anterior
cingulate
Reduced Sassi, 2009
Left orbitofrontal Reduced Reduced Eker, 2014
Left insula Reduced Reduced Matsuo, 2012
Right amygdala Increased Strakowski, 1999
Left amygdala Increased Strakowski, 1999
Lateral ventricles Increased Kempton, 2008*,
Arnone 2009*
Total cortex Reduced Arnone, 2009*
Right globus
pallidus
Increased Arnone, 2009*
Left globus pallidus Increased Arnone, 2009*
n
Meta-analysis. BPI, bipolar affective disorder type I. UFR, unaffected ﬁrst de-
gree relatives.
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subjects with BPI and control subjects with no personal or family
history of mental illness collected for genetic research studies of
bipolar disorder. Next, for those regions showing statistical dif-
ferences between BPI cases and control cases (subjects with no
personal or family history of BPI), we test whether a group of ﬁrst
degree relatives (with no personal history of mood or psychotic
disorders) of the BPI subjects also show differences in these brain
regions when compared with the control sample.
1.1. Brain regions previously associated with BPI
In our review of the literature, we identiﬁed a number of brain
regions that have been reported as differing in size between bi-
polar patients and unaffected controls. These regions of interest
are summarized below and in Table 1.
1.1.1. Prefrontal cortex
In the literature, there have been studies looking at the pre-
frontal cortex as a whole and in subsections. López-Larson et al.
(2002) reported that bipolar patients had smaller left and right
prefrontal gray matter volumes compared with controls. They also
reported speciﬁc substructures of these cortices (left superior and
middle prefrontal gray matter and right inferior and middle pre-
frontal gray matter volumes) differed in size between persons with
bipolar disorder and control subjects. Matsuo et al. (2012) also
found that subjects with BPI showed smaller right inferior frontal
gyrus gray matter volumes when compared with control subjects,
presumably referring to the right inferior prefrontal region.
1.1.2. Cingulate cortex
Sassi et al. (2004) used magnetic resonance imaging (MRI) to
compare the volumes of the left, right, anterior, and posterior
cingulate cortices between untreated bipolar mood disorder pa-
tients and healthy controls, and noted signiﬁcantly reduced left
anterior cingulate volumes in untreated subjects with bipolar
disorder (BPD) compared with control subjects with no history of
BPD.1.1.3. Orbitofrontal cortex
Eker et al. (2014) reported smaller volumes of the left orbito-
frontal cortex in patients with BPD compared with unrelated
control subjects with no history of BPD, and found the same was
true for healthy siblings of the bipolar patients compared with
unrelated controls; they postulated that this difference may be a
risk marker for BPD. Nery et al. (2009) conducted an anatomical
MRI study where they examined orbitofrontal cortex gray matter
volumes in subjects with BPD compared with control subjects.
Although they did not identify any volumetric differences between
subjects with and without BPD, they noted that orbitofrontal
cortex gray matter volumes were inversely correlated with de-
pressive symptom severity, suggesting that orbitofrontal cortex
gray matter reductions could be associated with the depressive
features of BPD.
1.1.4. Insula
Matsuo et al. (2012) found statistically signiﬁcant reductions in
volume of the left anterior insula grey matter with BPD subjects
compared with controls.
1.1.5. Amygdala
Strakowski et al. (1999) reported signiﬁcantly larger amygdala
size (bilaterally) in subjects with BPD compared with controls.
Eker et al. (2014) reported smaller left orbitofrontal cortex in pa-
tients with BPD compared with unrelated control subjects, and
found the same was true for healthy siblings of the bipolar pa-
tients compared with unrelated controls; they suggested that this
difference could be a risk marker for BPD.
Recent meta-analyses have also suggested several brain regions
which may differ between BPD subjects and controls. These in-
clude the following regions:
1.1.6. Lateral ventricles
In a meta-analysis by Kempton et al. (2008), lateral ventricular
enlargement was reported in subjects with BPD. This ﬁnding was
also revealed in the meta-analysis of Arnone et al. (2009), which
found both left and right ventricles to be signiﬁcantly enlarged in
subjects with BPD compared with controls.
1.1.7. Whole brain volume reduction
A meta-analysis of MRI studies of bipolar disorder and schizo-
phrenia by Arnone et al. (2009) found whole brain reductions in
subjects with BPD compared with controls.
1.1.8. Globus pallidus
Arnone et al. (2009), in a meta-analysis, reported that subjects
with BPD showed increases in size of the globus pallidus (bilat-
erally) compared with controls.
1.2. Goals of the current study
In this study, we used automated structural brain segmentation
and quantiﬁcation to investigate which, if any, of these 15 regions
(Table 1) would meet some of the key criteria for being an en-
dophenotype for BPI in a new sample of subjects. Speciﬁcally, we
hypothesized that each of these regions would show volumetric
differences between BPI subjects and unrelated healthy controls.
For any region that met this criterion in our sample, we then
proceeded to test whether unaffected ﬁrst degree relatives (UFR)
of BPI subjects would also show similar differences in volume
compared with unrelated healthy controls. Brain structures that
satisﬁed both of these criteria in the present study would satisfy
key criteria needed to deﬁne an endophenotype for bipolar dis-
order: differences in a quantiﬁable measure between BPI cases and
controls, and similar differences between unaffected relatives of
Table 3
Comparison of brain regions of interest between cases and controls in the current
study.
Region Volume change P value Volume change P value
H. Sandoval et al. / Psychiatry Research: Neuroimaging 247 (2016) 34–4136BPI cases and controls. In addition to testing these speciﬁc regions,
we also performed post hoc analyses on a large number of addi-
tional brain regions, bilaterally, to see if we could identify any
novel regions of potential interest as endophenotypes for BPI.for BPI compared
with controls
for UFR compared
with controls
Right prefrontal Reduced 0.003ǂ Reduced 0.0005ǂ
Right middle
prefrontal
Reduced 0.005ǂ Reduced 0.003ǂ
Right inferior
prefrontal
Reduced 0.017ǂ Reduced 0.034
Left prefrontal Reduced 0.0263 Reduced 0.001ǂ
Left superior
prefrontal
Reduced 0.069n Reduced 0.0009ǂ
Left middle
prefrontal
Reduced 0.041 Reduced 0.002ǂ
Left anterior
cingulate
Reduced NS Reduced NT
Left orbitofrontal Reduced NS Reduced NT
Left insula Reduced NS Reduced NT
Right amygdala Reducednn 0.073n Reducednn NS
Left amygdala Reducednn NS Reducednn NT
Ventricles Increased NS Reduced NT
Total cortex Reduced NS Reduced NT
Right globus
pallidus
Reduced 0.012ǂ Reduced 0.01ǂ
Left globus
pallidus
Reduced 0.014ǂ Reduced 0.0004ǂ
BPI, bipolar affective disorder type I. UFR, unaffected ﬁrst degree relatives.
NS¼Non-signiﬁcant (p40.05).
NT¼not tested.
ǂ ¼ Signiﬁcant after Bonferroni correction (po0.025)
n
Approaching signiﬁcance.
nn
Volume change is in a different direction than that observed in the literature
review.2. Methods
2.1. Subjects and diagnostic assessments
Demographic variables for the subjects in this study are shown in Table 2. All
subjects in the current study were recruited in San Antonio, Texas. BPI patients (7
males, 11 females) and ﬁrst degree relatives of BPI subjects who had no history of
mood disorder (UFRs) (5 males, 7 females) were recruited as part of the study
“Genetics of Bipolar Disorder in Latino Populations” (R01MH069856). A bilingual
psychiatrist completed a semi-structured interview for all affected subjects (BPI
cases and bipolar spectrum phenotypes) as well as all possible ﬁrst degree relatives
in each pedigree using the Diagnostic Interview for Genetic Studies (DIGS; Nurn-
berger et al., 1994). Interviewing psychiatrists were blind to any familial relation-
ship between subjects. A Family Interview for Genetic Studies (FIGS; Maxwell,
1992) was also completed for each family, which gave additional clinical in-
formation regarding all subjects in the family. Clinical data from these interviews,
along with medical and psychiatric records, were used by a best estimate team
consisting of psychologists and psychiatrists to assign ﬁnal consensus diagnoses
using DSM-IV criteria (Gonzalez et al., 2013) as well as diagnoses of history of
manic, depressed, and psychotic episodes or syndromes. All BPI subjects used in
these analyses met full DSM-IV criteria for BPI, by consensus best estimate diag-
nosis. Since the subjects were initially diagnosed, the DSM-5 has been published.
All of our subjects diagnosed as BPI by DSM-IV criteria also meet the criteria for BPI
as deﬁned by the DSM-5.
First degree relatives selected for analysis in the present study had no history of
psychosis, and no history of full depressive or manic episodes or syndromes. In
addition they, as well as the BPI subjects, had no current alcohol/substance abuse or
dependence. Of the ﬁrst degree relatives, seven had no history of any Axis I dis-
order, two had a history of speciﬁc phobias only, and the remaining three had only
a history of bereavement (not meeting criteria for depression). All ﬁrst degree re-
latives included in this analysis had at least one ﬁrst degree relative (sibling, parent,
or child) that met criteria for BPI by consensus best estimate diagnoses using the
procedures mentioned above.
Control (C) subjects (7 males, 11 females) were recruited from the local com-
munity, also in San Antonio, Texas, and had no DSM-IV axis I disorders, as de-
termined by the SCID-IV non-patient version interview (SCID-NP). Moreover, they
had no current medical problems, and no history of psychiatric disorders among
ﬁrst degree relatives.
2.2. Imaging data acquisition
T1-weighted MRI brain scans were acquired on a 3T Siemens (Erlangen, Ger-
many) Trio scanner with an eight-channel head coil in the Research Imaging In-
stitute, University of Texas Health Science Center at San Antonio, using the fol-
lowing scan parameters: isotropic anatomic images (800 μm), echo time¼2.83 ms,
repetition time¼2200 ms, ﬂip angle¼13°.
2.3. MRI image pre-processing
All T1-weighted MRI scans were visually inspected to rule out any gross arti-
facts. Freesurfer software (http://surfer.nmr.mgh.harvard.edu/) Version 5.3.0
(Fischl, 2012) was used to segment and parcellate the cerebral cortex into 34 re-
gions of interest using a pre-deﬁned atlas (Desikan et al., 2006). Anatomical vo-
lumes were exported for statistical analyses. Components of the prefrontal cortexTable 2
Demographic descriptive statistics.
Variable Bipolarnn UFR Healthy control
Mean (SD) Mean (SD) Mean (SD)
Age 38.9 (11.2) 43.4 (19.4) 37.2 (12.6)
Years of education 12.1 (2.9) 10.4 (2.3) 14.9 (3.4)
Age of onsetn Gender 24.6 (10.1) – –
Male (1) 7 (38.89%) 5 (41.67%) 7 (38.89%)
Female (2) 11 (61.11%) 7 (58.33%) 11 (61.11%)
UFR, unaffected ﬁrst degree relatives.
n
Onset of BPI diagnosis deﬁned by age at ﬁrst full manic episode (12–42).
nn
Frequency and percentage are reported.were analyzed individually and also as a region to provide information about vo-
lume differences in these speciﬁc areas. Prefrontal cortex volumes were calculated
by adding the superior frontal, rostral middle frontal, caudal middle frontal, pars
opercularis, pars triangularis, and pars orbitalis Freesurfer volumes. In post hoc
analyses, we also assessed the dorsolateral prefrontal cortex, deﬁned by combining
superior frontal, rostral middle frontal and caudal middle frontal volumes, on both
the left and right sides of the brain.
2.4. Image and statistical analyses
All analyses were conducted using SAS V.9.3. The ﬁrst set of analyses performed
involved attempts to replicate the 15 speciﬁc brain regions (Table 1) that had
previously been shown to signiﬁcantly differ between subjects with BPI and control
subjects. A linear regression analysis with age and gender corrections was con-
ducted for control vs. BPI subjects and also for controls vs. UFR subjects on those
speciﬁc brain regions of interest (Table 3). As each of these expected differences
was an a priori hypothesis (previously shown to be signiﬁcant), we set a threshold
for signiﬁcant replication at po0.05. For the given sample size in these analyses,
using measures of the globus pallidus as an example, we had moderate power
(450%) to detect differences in regions of interest between groups at an alpha p
value of 0.05 or less.
Since each of the sections that showed signiﬁcant differences between BPI
cases and controls (po0.05) was then also tested between unaffected ﬁrst degree
relatives and the same control samples, we required an adjustment for the fact that
two comparisons were done using the same control group, and statistical adjust-
ment (Bonferroni) thus required a p value less than 0.025 (0.05/2) to meet criteria
for signiﬁcance. Table 3 presents p values without Bonferroni correction (these are
nominal p values). Those passing a Bonferroni correction for signiﬁcance are
highlighted in Table 3 with the symbol ǂ.
In post hoc analyses a linear regression with age and gender corrections was
conducted for C vs. BPI subjects and also for C vs. UFR subjects on a number of
additional brain regions that were not in our list of hypothesized regions. These
regions included structures on the opposite side of hypothesized regions, left and
right total cortical volume, and a number of additional substructures of hypothe-
sized regions on both left and right sides of the brain (Table 4). As we were not
testing speciﬁc a priori hypotheses here, the p values reported in Table 4 are
nominal (uncorrected). In order for any of these to pass the threshold for sig-
niﬁcance, considering multiple testing, at the strictest level, we suggest a statistical
adjustment which corrects for 13 independent regions (all listed sections except for
the subsections of the prefrontal cortices) and two tests (BPI vs. controls and UFR
Table 4
Post hoc adjusted associations of variables with diagnosis after adjusting for age
and gender using multiple linear regression analysis.
Variables Regression coefﬁcient (95% C.I.) P-value
Left prefrontal
Bipolar vs. healthy control 3677.7 (6901.7,453.6) 0.0263
UFR vs. healthy control 6337.8 (9994.9,2680.7) 0.001a
LDLPFC
Bipolar vs. healthy control 2993.8 (5714.1,273.5) 0.031
UFR vs. healthy control 5791.4 (8877,2705.8) 0.0005a
Left rostral middle prefrontal
Bipolar vs. healthy control 1442.8 (3006.1, 120.5) 0.006a
UFR vs. healthy control 3123.8 (4897.2,1350.5) 0.001a
Left caudal middle prefrontal
Bipolar vs. healthy control 115.1 (955.8, 725.4) 0.783
UFR vs. healthy control 646.8 (1600.3, 306.7) 0.178
Left inferior prefrontal
Bipolar vs. healthy control 683.8 (1558.3, 190.6) 0.122
UFR vs. healthy control 546.4 (1538.3, 445.4) 0.272
Left pars opercularis
Bipolar vs. healthy control 489.9 (994.7, 14.9) 0.056
UFR vs. healthy control 413.9 (986.6, 158.6) 0.152
Left pars triangularis
Bipolar vs. healthy control 212.3 (633.1, 208.4) 0.314
UFR vs. healthy control 6.43 (483.6, 470.7) 0.978
Left pars orbitalis
Bipolar vs. healthy control 18.42 (190.2, 227.03) 0.859
UFR vs. healthy control 126 (362.6, 110.6) 0.289
Left inferior temporal gyrus
Bipolar vs. healthy control 541.6 (1227.4, 144.1) 0.118
UFR vs. healthy control 432.8 (1210.6, 344.9) 0.268
Left middle temporal gyrus
Bipolar vs. healthy control 496.1 (1093.5, 101.4) 0.101
UFR vs. healthy control 287.2 (964.9, 390.4) 0.397
Left temporal pole
Bipolar vs. healthy control 8.39 (255.7, 272.5) 0.949
UFR vs. healthy control 57.4 (242.2, 357.04) 0.701
Right cortex
Bipolar vs. healthy control 10265.3 (22391.9, 1861.2) 0.09
UFR vs. healthy control 20550.6 (34305.8,6795) 0.004a
RDLPFC
Bipolar vs. healthy control 3933.3 (6641.2,1225.4) 0.005a
UFR vs. healthy control 5605.5 (8677.1,2533.9) 0.0006a
Right superior prefrontal
Bipolar vs. healthy control 1499.5 (2839.4,159.7) 0.029
UFR vs. healthy control 2681 (4200.8,1161.2) 0.0009a
Right rostral middle prefrontal
Bipolar vs. healthy control 1992.3 (3289.8,394.8) 0.003a
UFR vs. healthy control 1806.1 (3277.8,334.3) 0.017a
Right caudal middle prefrontal
Bipolar vs. healthy control 441.4 (1102.6, 219.7) 0.185
UFR vs. healthy control 1118.4 (1868.4,368.4) 0.004a
Right pars opercularis
Bipolar vs. healthy control 214.1 (606.8, 178.5) 0.277
UFR vs. healthy control 437.2 (882.6, 8.22) 0.054
Right pars triangularis
Bipolar vs. healthy control 520.1 (952.1,88.04) 0.019a
UFR vs. healthy control 329.5 (879.6, 160.5) 0.182
Right pars orbitalis
Bipolar vs. healthy control 116.2 (340.4, 107.9) 0.301
UFR vs. healthy control 81.9 (336.2, 172.3) 0.519
Right orbitofrontal
Bipolar vs. healthy control 302.4 (1138.5, 533.6) 0.469
UFR vs. healthy control 1422.9 (2371.3,474.6) 0.004a
Right anterior cingulate
Bipolar vs. healthy control 558.1 (1174.1, 57.83) 0.074
UFR vs. healthy control 1012.3 (1711.1,313.6) 0.005a
Right insula
Bipolar vs. healthy control 116.6 (595.8, 362.6) 0.626
UFR vs. healthy control 910.2 (1453.8,366.7) 0.001a
Right inferior temporal gyrus
Bipolar vs. healthy control 631.5 (1308.6, 45.6) 0.066
UFR vs. healthy control 412.4 (1180.5, 355.6) 0.284
Right middle temporal gyrus
Bipolar vs. healthy control 430.7 (1120, 258.6) 0.214
UFR vs. healthy control 861.8 (1643.7,80.04) 0.031
Right temporal pole
Bipolar vs. healthy control 88.2 (552.02, 375.6) 0.703
Table 4 (continued )
Variables Regression coefﬁcient (95% C.I.) P-value
UFR vs. healthy control 200.4 (325.6, 726.6) 0.446
a ¼Signiﬁcant after Bonferroni correction (po0.019). UFR, unaffected ﬁrst
degree relatives. LDLPFC, left dorsolateral prefrontal cortex. RDLPFC, right dorso-
lateral prefrontal cortex.
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considered signiﬁcant.
Continuous data are summarized for each region of interest studied, for the C,
UHR, and BPI groups, using means and standard deviations in Table 5.3. Results
Results of the 15 regions (all hypothesized to be different in size
between BPIs and controls based on literature review) tested are
summarized in Table 3. Seven of these regions met our a priori
criterion (po0.05) for a signiﬁcant difference in size between BPI
subjects and controls. After correction for multiple testing, regions
that still showed signiﬁcant differences between BPI and control
subjects (at po0.025) included the right prefrontal cortex (and
the right middle prefrontal and right inferior prefrontal subsec-
tions) and the right and left globus pallidum. The left prefrontal,
left superior prefrontal, left middle prefrontal cortex and right
amygdala showed non-signiﬁcant (after Bonferroni correction)
trends (p¼0.0263, p¼0.069, p¼0.041 and p¼0.073, respectively)
toward differences in size between BPI subjects and controls.
When total cortical volume is included as an additional co-variable
(in addition to gender and age), regions showing signiﬁcant dif-
ferences (po0.025) between cases and controls are similar: right
prefrontal (p¼0.0004), right middle prefrontal (p¼0.002), right
inferior prefrontal (p¼0.028), left prefrontal region (p¼0.016), and
both left and right globus pallidus (p¼0.024 and p¼0.017),
respectively.
As shown in Table 3, four (right prefrontal, right middle pre-
frontal, right and left globus pallidus) of the ﬁve regions which
showed signiﬁcant size differences (after Bonferroni correction)
between BPI and C subjects also showed Bonferroni-corrected
signiﬁcant size differences (po0.025) between the UFR and con-
trol samples. When total cortical volume is added as an additional
co-variable (in addition to gender and age), only the left globus
pallidus is signiﬁcant at the level of po0.05 in both BPI subjects
vs. controls (p¼0.024) and UFR subjects vs. controls (p¼0.015).
In post hoc analyses (Table 4), we examined a number of ad-
ditional brain regions that were not in our list of hypothesized
regions. This included structures on the opposite side of hy-
pothesized regions (left prefrontal, right orbitofrontal, right ante-
rior cingulate, right superior frontal), separate analyses of left and
right total cortical volume, and a number of additional structures
and substructures on both the left and right sides of the brain
(dorsolateral prefrontal cortex, rostral middle frontal, caudal
middle frontal, insula, temporal gyri, temporal poles, pars oper-
cularis, pars triangularis, pars orbitalis). Of note, this identiﬁed the
following additional structures which met nominal criteria (dif-
ferences between BPI vs. control subjects and UFR vs. control
subjects, both at po0.05): left and right dorsolateral prefrontal
cortex, right superior prefrontal cortex, and left and right rostral
middle prefrontal cortex. After Bonferroni correction for multiple
testing (see Section 2), only the following regions showed sig-
niﬁcant (po0.0019) differences between UFR vs. control subjects
in these post hoc analyses: right and left prefrontal cortex, right
and left dorsolateral prefrontal cortex, left rostral middle pre-
frontal, right superior prefrontal, and right insula. When total
cortical volume is included as a co-variable (in addition to gender),
Table 5
Descriptive statistics of left and right mean volumes (SD) with respect to group.
Variable Bipolar (n¼18) UFR (n¼12) Healthy control (n¼18)
Left superior prefrontal 21900.4 (3198.5) 19822.5 (2913.4) 23522.6 (3400.2)
Left rostral middle prefrontal 14913.7 (2379.3) 14122.2 (1381.3) 16450.7 (2258.5)
Left caudal middle prefrontal 6533.06 (1187.3) 5862.8 (1598.4) 6710.2 (1559.8)
Left middle prefrontal 21446.76 19985 23160.9
Left pars opercularis 4754.3 (788.6) 4691 (1232.1) 5304.7 (1046.4)
Left pars triangularis 3528.8 (749.6) 3659.2 (730.4) 3774.5 (702.3)
Left pars orbitalis 2162.2 (414.6) 1982 (378.3) 2160.8 (363.9)
Left inferior prefrontal 10445.3 10332.2 11240
Right superior prefrontal 20659.06(3097.8) 19111.4 (2702.4) 22321.9 (2513.6)
Right rostral middle prefrontal 15216.9 (2525.5) 15201.2 (1847.3) 17314.6 (3058.7)
Right caudal middle prefrontal 6163 (1265.4) 5381.5 (1373.9) 6654.1 (974.2)
Right middle prefrontal 21379.9 20582.7 23968.7
Right pars opercularis 3964.6 (738.9) 3595 (698.5) 4235.2 (803.8)
Right pars triangularis 4024.5 (609.1) 4145.8 (547.6) 4575.6 (933.2)
Right pars orbitalis 2460.5 (465.1) 2466.7 (339.2) 2591.2 (387.5)
Right inferior prefrontal 10449.6 10207.5 11402
Right prefrontal 52488.6 (7210.3) 49901.7 (6671) 57692.9 (7187.6)
Left prefrontal 53792.7 (7473.8) 50139.8 (6813.5) 57923.7 (7975)
LDLPFC 43347.2 (6158.6) 39807.5 (5366.5) 46683.6 (6298.8)
RDLPFC 42039 (6336.94) 39694.1 (5419.1) 46290.7 (5911.5)
Left orbitofrontal 13180.3 (1762.1) 11855.7 (1632.6) 13289 (1918.3)
Right orbitofrontal 12731.7 (1747.3) 11474.5 (1185.7) 13103 (1770.8)
Left anterior cingulate 4160.61 (967.73) 3743.2 (608.4) 4261 (1068.5)
Right anterior cingulate 4304.28 (1009) 3813.5 (931.2) 4890.06 (1414.6)
Left lateral ventricle 8468.6(4389.3) 7318.7(5055.7) 8280.5(5271)
Right lateral ventricle 8006.3(4041.2) 7194.8(4930.5) 7165.8(4363.8)
Lateral ventricles 16474.98 (8089.76) 14513.63 (9793.94) 15446.36 (9223.29)
Left cortex 222862.4(28161.4) 211043.6(20571.3) 231905.5(28273.8)
Right cortex 222810.1(28970) 210669.9(19757.9) 234115.4(28022.7)
Cortex 445672.6(57061.4) 421713.5(40218) 466021(56200.9)
Left amygdala 1336.9(210.9) 1275.5(156.8) 1414.4(191.6)
Right amygdala 1366.4(195.5) 1381.4(161.7) 1469.2(195.4)
Right globus pallidus 1448.9(279.1) 1385.2(294.8) 1676.8(273.9)
Left globus pallidus 1640.3(273.8) 1481.8(317) 1845.4(239.9)
Left insula 6886.7(1051.5) 6295.6(787.1)) 7268(1306)
Right insula 7038.1(1023.3) 6295(628.8) 7149.8(1090.6)
Left temporal gyrus (inferior) 6227.8(905.1) 6319.8(1061.1) 6786.7(1386.3)
Left temporal gyrus (middle) 6979.8(1091.5) 7121(995.3) 7512(1123.7)
Left temporal pole 4576.8(684.7) 4798.5(572.4) 4366.8(859.6)
Right temporal gyrus (inferior) 5908.3(1150.1) 6082.2(907.1) 6567.1(1265.9)
Right temporal gyrus (middle) 7715.8(1271.8) 7160.3(1194.9) 8204.6(1335.9)
Right temporal pole 4489(660.6) 4796.6(755.3) 4572.4(654.7)
Values in cubic millimeters (mm3). UFR, unaffected ﬁrst degree relatives. LDLPFC, left dorsolateral prefrontal cortex. RDLPFC, right dorsolateral prefrontal cortex.
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different between cases and controls, beyond those listed above
(right and left prefrontal regions and globus pallidum differ be-
tween BPI vs control subjects, and left globus pallidus differs be-
tween UFR and control subjects).4. Discussion
The current study attempted to identify potential brain struc-
tures, deﬁned by MRI, which would meet the criteria for being
endophenotypes for BPI. We ﬁrst tested a number of structures
that previous studies had identiﬁed as being altered in size in BPI
compared with control subjects, conﬁrming that the right pre-
frontal cortex and both the right and left pallidal structures dif-
fered in size between BPI subjects and controls. The left prefrontal
cortex also showed a nearly signiﬁcant difference (p¼0.0263) in
size between BPI cases and controls. In addition, all of these
structures showed differences in size between UFR subjects and
controls. For each of these structures, the differences in size be-
tween BPI subjects and controls (as well as between UFR subjects
and controls) was in the same direction as predicted from the
literature, with the exception of the left and right globus pallidum
(which were both decreased in size for BPI and UFR subjectscompared with controls).
4.1. Prefrontal regions
Clearly, the bilateral prefrontal cortex represents a promising
area for future research attempting to identify endophenotypes for
BPI. The right prefrontal cortex met our criteria for being a po-
tential endophenotype. Bilaterally, the dorsolateral prefrontal
cortices, superior and middle frontal cortices, as deﬁned in the
current study, all showed nominal evidence of being reduced in
size for both BPI subjects and UFR subjects compared with con-
trols. This suggests that a decrease in these structures is not just
related to having a diagnosis of BPI disorder but is also a marker
for genetic risk of BPI (i.e., unaffected relatives who are at genetic
risk for BPI but have not presented any manic or depressed epi-
sodes also show decreases in these structures). Where to draw the
line regarding where the “prefrontal” structures are altered in
those at genetic risk for BPI is unclear, as, based on data from our
study, one could ﬁnd a number of the substructures meeting cri-
teria for being endophenotypes. We report on all of these (in-
cluding dorsolateral prefrontal cortex) in this article so that these
data will be available for researchers interested in which portions
of the frontal cortices may be pertinent as endophenotypes for BPI.
Our ﬁndings indicating that these prefrontal regions are
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sistent with the literature, which has shown that cognitive func-
tions that rely on prefrontal cortical activity, such as working
memory and executive function, are altered in persons with bi-
polar disorder compared with controls. Of course, it is difﬁcult to
exactly map neurocognitive functions onto brain anatomy, as they
typically involve several regions of the brain. Functional imaging
studies have shown that there are speciﬁc activation abnormalities
in bipolar patients in both dorsolateral prefrontal cortices while
they perform speciﬁc tasks (Glahn et al., 2010). Functional MRI
research has also suggested that decreased activity in the dorso-
lateral prefrontal cortex regions is a feature of both mania and
depression in bipolar patients in comparison to controls (Pomarol-
Clotet et al., 2014). Lee et al. (2014) have also shown decreased
activation in the dorsolateral prefrontal cortex in pediatric bipolar
cases compared with controls. Our ﬁndings are also consistent
with a recent study by Fears et al. (2014) which showed that
characteristics of dorsolateral prefrontal cortex and inferior frontal
cortex regions are both heritable and associated with bipolar
disorder in extended pedigrees.
As to whether the prefrontal cortices (bilaterally) or speciﬁc
subregions within these areas are genetically correlated with bi-
polar disorder, our results suggest that several ways of parsing this
region of the brain will meet the necessary criteria for use as en-
dophenotypes. Potentials areas include left and right prefrontal
cortex (as deﬁned in Section 2), right or left dorsolateral prefrontal
cortex (as deﬁned in Section 2), and a number of subregions (left
and right rostral middle prefrontal, right inferior prefrontal).
4.2. Globus pallidus and amygdala
Previous research has implicated the globus pallidus (bilat-
erally) as a region that is altered in size in bipolar subjects com-
pared with controls (Strakowski et al., 1999). Although our re-
search found signiﬁcant differences in globus pallidus size be-
tween both BPI and UFR subjects compared with controls, the
differences in size were in the opposite direction from the ﬁndings
by Strakowski et al. (Table 1). In the study by Strakowski et al., the
bipolar patients had an average duration of illness of 6 years, in
comparison to our subjects, who on average had a duration of
illness of over 14 years (Table 2). The differences in our ﬁndings
may therefore reﬂect changes in the globus pallidus which occur
over time in the course of bipolar disorder. Additionally, clinical
differences such as medications, comorbidities and number of
episodes of depression and mania may account for the differences
observed in our study and the study of Strakowski et al. Interest-
ingly, a more recent study by Womer et al. (2014) showed that
non-psychotic bipolar patients showed reduced globus pallidus
size compared with controls, and the investigators suggested that
reduced globus pallidus size might relate to depression (a pro-
minent component of bipolar disorder). Medications, particularly
ﬁrst generation antipsychotics, may affect globus pallidus size over
time, but such effects are thought to cause increases in size
(Boonstra et al., 2011). The exact roles of the globus pallidus in
emotion and cognition are not fully understood, but Womer et al.
(2014), based on their research on lesions in this area of the brain,
suggested that the globus pallidum may have roles in motivation,
sensitivity to reward effects, and depressive symptoms. In terms of
the amygdala, we did not ﬁnd support at the level of signiﬁcance
deﬁned a priori, for an association with BPI, but we did show the
right amygdala size to be approaching statistically signiﬁcant dif-
ferences in BPI compared to control subjects, and we also found
the left amygdala to be signiﬁcantly different in size in UFR sub-
jects compared with controls. Interestingly, we also found the
differences in amygdala size to be in the opposite direction to that
reported on by Strakowski et al. Both studies suggest that globuspallidus and amygdala structures are potentially of interest as
phenotypes related to bipolar disorder, but our ﬁndings suggest
that the prefrontal cortex and several of its substructures are more
likely to serve as consistent endophenotypes for BPI.
4.3. Total cortex and ventricle sizes
Our data did not support ﬁndings from previous meta-analyses
which showed total cortex size and ventricle sizes differed be-
tween bipolar subjects and controls, in the sense that we did not
ﬁnd signiﬁcant (po0.05) evidence in our sample (Table 3). As the
previous ﬁndings that generated this hypothesis (Arnone et al.,
2009) derived from meta-analyses combining large numbers of
samples, it is possible that the small sample size of the current
study was not well suited to capture such differences. Interest-
ingly, when total cortical volume was included as a co-variate in
our linear regression analyses, differences between BPI and control
subjects still emerged in the right and left prefrontal regions and
the right and left globus pallidum, but only the left globus pallidus
(out of these regions) was also statistically signiﬁcant between
UFR and control subjects. Thus, if total cortical volume is included
as a co-variable in our population-based studies, the left globus
pallidum may be the best candidate to follow as an
endophenotype.
4.4. Markers for disease state versus markers for genetic risk
Although the thrust of the current analyses was to test hy-
potheses regarding which brain structures are suitable for use as
endophenotypes for BPI, it is useful to look at which of these traits
might serve as markers of genetic risk for disease and which might
serve as markers of the disease state itself. The following brain
structures all meet nominal criteria (po0.05) in our sample as
differing in BPI subjects compared with controls, thus serving as
potential markers of disease state for BPI: the right prefrontal cor-
tex and its subsections (right middle prefrontal, right inferior
prefrontal, right dorsolateral prefrontal, right rostral middle fron-
tal), left prefrontal cortex and its subsections (left superior pre-
frontal, left middle prefrontal, left dorsolateral prefrontal, left
rostral middle frontal), right and left globus pallidum, and (ap-
proaching signiﬁcance) right amygdala. By contrast, our data
support the following structures as meeting nominal criteria
(po0.05) for differing between UFR and control subjects, thus
qualifying as potential markers of genetic risk for BPI: the right and
left prefrontal cortex and the subsections listed above, left and
right globus pallidum, left and right orbitofrontal cortex, left and
right insular cortex, left amygdala, right middle temporal gyrus,
and total cortex (and its subsections, right and left cortex). Long-
itudinal studies would be necessary to further test how these
different regions may be used as markers of genetic risk and dis-
ease state and progression.
4.5. Limitations, future research and concluding remarks
One limitation of the current study is the small sample size. The
sample size had moderate power (50–60%) to detect statistically
signiﬁcant differences in the identiﬁed regions of interest. Future
studies with a larger sample would be useful in order to conﬁrm
the present results, as well as to determine if some additional
regions which were below our threshold of signiﬁcance, might be
potential endophenotypes as well. Longitudinal studies of persons
with BPI as well as persons at risk for BPI would also be of use to
determine how these anatomical differences might change over
time. Longitudinal studies of patients with BPI would be useful
from onset through progression of illness to better understand
how episodes, psychiatric comorbidities, and pharmacologic and
H. Sandoval et al. / Psychiatry Research: Neuroimaging 247 (2016) 34–4140psychological therapies might moderate changes in these struc-
tures over time. Finally, more detailed, pedigree-based studies
would be useful to determine how these brain regions co-segre-
gate with BPI in multiplex families and to identify the speciﬁc
genes contributing to these endophenotypes (especially those in
both left and right prefrontal cortex regions) and therefore, ulti-
mately, to the pathophysiology of bipolar disorder. Our data sup-
port that a signiﬁcant amount of the genetically controlled biolo-
gical activity which plays a role in bipolar disorder does so through
prefrontal structures bi-laterally. As these are brain structures also
known to be involved in the psychopathology of schizophrenia, it
will be an important area of future research to better distinguish
both the genetic and pathophysiologic overlap and differences
between subjects with bipolar disorder and schizophrenia.
Given the paucity of bipolar neuroimaging research that has
been conducted in subjects of Latino ancestry, it is interesting to
note that the current sample involved all Latino subjects, primarily
of Mexican ancestry, living in South Texas. Given the small size of
the sample and the fact that it derived from one geographical
region, extrapolation to the entire Latino population should be
done with caution. Given that the literature has not found sig-
niﬁcant differences in the epidemiology or characteristics of bi-
polar disorder between Hispanic and non-Hispanic populations
(Burnam et al., 1987), we have no reason to suspect a priori that
the biological endophenotypes for bipolar disorder will be sig-
niﬁcantly different across populations. Our data in general support
this conclusion, as at least seven of the hypothesized regions (from
studies conducted in largely non-Latino populations) were con-
ﬁrmed in the present study. The one other published study of
which we are aware, conducted in Latino populations from Co-
lombia and Costa Rica (Fears et al., 2014), found similar results to
our current study, with regard to dorsolateral prefrontal cortex
and inferior prefrontal cortex regions being strong candidates as
endophenotypes for bipolar disorder. Clearly, additional research
in the Latino population is needed to make the current results
more generalizable to Latinos from other regions of the world.
Collectively, this research demonstrates an important, but often
understudied piece of the bipolar disorder puzzle. Unaffected fa-
mily members show signiﬁcantly lower total cortical volume, as
well as lower volumes in a number of network regions, than
healthy controls. Many of these differences in structure are also
seen in BPI patients, but there are also some differences between
the BPI patients and the unaffected relatives. To us, this highlights
the importance of longitudinal studies; it may be the case that as
BPI progresses, and potentially as a result of treatment, some of
these brain regions remain altered in size while others normalize
or change in opposite directions from those in the family members
who do not develop BPI. Indeed, it may be the case that additional
factors not tested here (environmental factors, treatment, or co-
morbidities) inﬂuence the time course of how markers of BPI ge-
netic risk develop and alter over time.Author contributions
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